Last reviewed · How we verify

NCT06579560

Audio Vestibular Assessment in Patients with Fibromyalgia

Recruiting now Last updated 30 August 2024
What this trial tests

trial testing Audiovestibular assessment in Patients with Fibromyalgia in Fibromyalgia in 4 participants. Currently enrolling.

Timeline
16 April 2023
Primary endpoint
16 April 2025
16 April 2025

Quick facts

Lead sponsorNoha Osman
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment4
Start date16 April 2023
Primary completion16 April 2025
Estimated completion16 April 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Noha Osman

Who can join

Adults 15 to 50, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fibromyalgia (FM) is a common rheumatic illness distinguished by chronic pain, fatigue, cognitive problems, and functional disability. However, the differences between men and women have not yet been comprehensively studied, especially after the development of the last 2016 American College of Rheumatology (ACR) criteria. The disease is more common and more severe in female patients according to a study on gender differences among Egyptian patients (A. Moshrif et al., 2023)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Noha Osman trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06579560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing